Inhibition of extracellular signal-regulated kinase pathway suppresses tracheal stenosis in a novel mouse model
Open Access
- 29 September 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0256127
Abstract
Tracheal stenosis is a refractory and recurrent disease induced by excessive cell proliferation within the restricted tracheal space. We investigated the role of extracellular signal-regulated kinase (ERK), which mediates a broad range of intracellular signal transduction processes in tracheal stenosis and the therapeutic effect of the MEK inhibitor which is the upstream kinase of ERK. We histologically analyzed cauterized tracheas to evaluate stenosis using a tracheal stenosis mouse model. Using Western blot, we analyzed the phosphorylation rate of ERK1/2 after cauterization with or without MEK inhibitor. MEK inhibitor was intraperitoneally injected 30 min prior to cauterization (single treatment) or 30 min prior to and 24, 48, 72, and 96 hours after cauterization (daily treatment). We compared the stenosis of non-inhibitor treatment, single treatment, and daily treatment group. We successfully established a novel mouse model of tracheal stenosis. The cauterized trachea increased the rate of stenosis compared with the normal control trachea. The phosphorylation rate of ERK1 and ERK2 was significantly increased at 5 min after the cauterization compared with the normal controls. After 5 min, the rates decreased over time. The daily treatment group had suppressed stenosis compared with the non-inhibitor treatment group. p-ERK1/2 activation after cauterization could play an important role in the tracheal wound healing process. Consecutive inhibition of ERK phosphorylation is a potentially useful therapeutic strategy for tracheal stenosis.Keywords
Funding Information
- Grant-in-Aid for Challenging Exploratory Research (25670723)
- Grant-in-Aid for Scientific Research (16K11252)
- National Defense Medical College Special Research Grant
- Grants-in-Aid for Early-Career Scientists (40623137)
- Grant-in-Aid for Scientific Research (18K09390)
- Grant-in-Aid for Scientific Research (17K11415)
This publication has 33 references indexed in Scilit:
- Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1)Journal of Medicinal Chemistry, 2014
- MEK in cancer and cancer therapyPharmacology & Therapeutics, 2014
- TGF-β signaling in fibrosisGrowth Factors, 2011
- Basal cells as stem cells of the mouse trachea and human airway epitheliumProceedings of the National Academy of Sciences, 2009
- ERK2 dependent signaling contributes to wound healing after a partial-thickness burnBiochemical and Biophysical Research Communications, 2009
- Biphasic Regulation of AP-1 Subunits during Human Epidermal Wound HealingJournal of Investigative Dermatology, 2007
- Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancerOncogene, 2007
- Regulation of cocaine-induced activator protein 1 transcription factors by the extracellular signal-regulated kinase pathwayNeuroscience, 2006
- Tracheostomies in Burn PatientsAnnals of Surgery, 1989
- Upper Airway Sequelae in Burn Patients Requiring Endotracheal Intubation or TracheostomyAnnals of Surgery, 1985